REVIEW Nongenomic Signaling Pathways of Estrogen Toxicity

Xenoestrogens can affect the healthy functioning of a variety of tissues by acting as potent estrogens via nongenomic signaling pathways or by interfering with those actions of multiple physiological estrogens. Collectively, our and other studies have compared a wide range of estrogenic compounds, including some closely structurally related subgroups. The estrogens that have been studied include environmental contaminants of different subclasses, dietary estrogens, and several prominent physiological metabolites. By comparing the nongenomic signaling and functional responses to these compounds, we have begun to address the structural requirements for their actions through membrane estrogen receptors in the pituitary, in comparison to other tissues, and to gain insights into their typical non-monotonic dose-response behavior. Their multiple inputs into cellular signaling begin processes that eventually integrate at the level of mitogen-activated protein kinase activities to coordinately regulate broad cellular destinies, such as proliferation, apoptosis, or differentiation.

[1]  J. Adams Human breast cancer: Concerted role of diet, prolactin and adrenal C19‐Δ5‐steroids in tumorigenesis , 1992, International journal of cancer.

[2]  M. Nevalainen,et al.  Prolactin and prolactin receptors are expressed and functioning in human prostate. , 1997, The Journal of clinical investigation.

[3]  P. Dannies CHAPTER 9 – Control of Prolactin Production by Estrogen , 1985 .

[4]  T. Midoro-Horiuti,et al.  Environmental Estrogens Induce Mast Cell Degranulation and Enhance IgE-Mediated Release of Allergic Mediators , 2006, Environmental Health Perspectives.

[5]  C. Watson,et al.  Regulation of the membrane estrogen receptor‐α: role of cell density, serum, cell passage number, and estradiol , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  T. van Amelsvoort,et al.  Mood, cognition and Alzheimer's disease. , 2002, Best practice & research. Clinical obstetrics & gynaecology.

[7]  L. Sobrinho Prolactin, Psychological Stress and Environment in Humans: Adaptation and Maladaptation , 2004, Pituitary.

[8]  R. Holmdahl,et al.  Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. , 2001, Arthritis and rheumatism.

[9]  T. Pappas,et al.  Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α , 1999, Steroids.

[10]  Edward J. Filardo,et al.  GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release , 2005, Trends in Endocrinology & Metabolism.

[11]  U. Meinhardt,et al.  The Essential Role of the Aromatase/P450arom , 2002, Seminars in reproductive medicine.

[12]  M. von Zastrow,et al.  Regulated Endocytosis of G-protein-coupled Receptors by a Biochemically and Functionally Distinct Subpopulation of Clathrin-coated Pits* , 1998, The Journal of Biological Chemistry.

[13]  C. Watson,et al.  Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways , 2004, Steroids.

[14]  C. Watson,et al.  Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  S. Carreau,et al.  Testicular Estrogens and Male Reproduction. , 2000, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[16]  Jianying Hu,et al.  Products of aqueous chlorination of 4‐nonylphenol and their estrogenic activity , 2002, Environmental toxicology and chemistry.

[17]  Christina M. Morris,et al.  Dopaminergic polymorphisms in Tourette syndrome: Association with the DAT gene (SLC6A3) , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .

[19]  J. Hassan,et al.  Phytoestrogens levels determination in the cord blood from Malaysia rural and urban populations. , 2007, Toxicology and applied pharmacology.

[20]  T. Robbins,et al.  The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson’s disease , 2005, Journal of Neurology.

[21]  Jun Wang,et al.  Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. , 1998, Carcinogenesis.

[22]  L. Howells,et al.  Indole-3-carbinol enhances anti-proliferative, but not anti-invasive effects of oxaliplatin in colorectal cancer cell lines. , 2008, Biochemical pharmacology.

[23]  P. Thomas,et al.  Disruption of rapid, nongenomic steroid actions by environmental chemicals: interference with progestin stimulation of sperm motility in Atlantic croaker. , 2004, Environmental science & technology.

[24]  B. Vanderhyden,et al.  A new, nongenomic estrogen action: the rapid release of intracellular calcium. , 1992, Endocrinology.

[25]  Y. Shimohigashi,et al.  Structural requirements of para-alkylphenols to bind to estrogen receptor. , 1999, European journal of biochemistry.

[26]  D. Edwards,et al.  Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. , 2001, Molecular cell.

[27]  P. Shaul,et al.  Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae , 2002, Steroids.

[28]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.

[29]  R. Alyea,et al.  Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux , 2009, BMC Neuroscience.

[30]  S. Simons What goes on behind closed doors: physiological versus pharmacological steroid hormone actions , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  I. Raskin,et al.  Dietary phytoestrogens and health. , 2004, Phytochemistry.

[32]  R. Alyea,et al.  Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues , 2007, Molecular and Cellular Endocrinology.

[33]  M. Dudley,et al.  Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. , 1999, Environmental health perspectives.

[34]  T. Collins,et al.  Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin , 1994 .

[35]  J. Richie,et al.  Caveolin-1 Interacts with Androgen Receptor , 2001, The Journal of Biological Chemistry.

[36]  R. Santen,et al.  Estrogen rapid action via protein complex formation involving ERα and Src , 2005, Trends in Endocrinology & Metabolism.

[37]  W. Foster,et al.  Rapid effects of pesticides on human granulosa-lutein cells. , 2006, Reproduction.

[38]  Kristina A Thayer,et al.  Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.

[39]  C. Watson,et al.  Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells , 2004, Breast Cancer Research.

[40]  D. Barceló,et al.  Occurrence and removal of estrogenic short-chain ethoxy nonylphenolic compounds and their halogenated derivatives during drinking water production. , 2003, Environmental science & technology.

[41]  D. Singleton,et al.  Xenoestrogen exposure and mechanisms of endocrine disruption. , 2003, Frontiers in bioscience : a journal and virtual library.

[42]  J. Jameson,et al.  Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  F. Greenspan Basic and Clinical Endocrinology , 1990 .

[44]  Frederick S vom Saal,et al.  Components of plastic: experimental studies in animals and relevance for human health , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[45]  L. Schuler,et al.  Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. , 2003, Oncogene.

[46]  E. Bickoff,et al.  Coumestrol, a new estrogen isolated from forage crops. , 1957, Science.

[47]  T. Colborn,et al.  Neurodevelopment and Endocrine Disruption , 2003, Environmental health perspectives.

[48]  T. Mabry,et al.  Flavonoid effects relevant to cancer. , 2002, The Journal of nutrition.

[49]  S. Swan,et al.  Bisphenol A Data in NHANES Suggest Longer than Expected Half-Life, Substantial Nonfood Exposure, or Both , 2009, Environmental health perspectives.

[50]  D. Naiman,et al.  Bisphenol A (BPA) daily intakes in the United States: Estimates from the 2003–2004 NHANES urinary BPA data , 2008, Journal of Exposure Science and Environmental Epidemiology.

[51]  C. Watson,et al.  Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases , 2009, BMC Cancer.

[52]  D. Schaid,et al.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[53]  J. Farrar,et al.  Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors , 2009, Cancer.

[54]  Adrian V. Lee,et al.  Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells , 2004, Molecular and Cellular Endocrinology.

[55]  M. Reinhard,et al.  Occurrence and fate of pharmaceuticals and alkylphenol ethoxylate metabolites in an effluent‐dominated river and wetland , 2004, Environmental toxicology and chemistry.

[56]  B S Peterson,et al.  Pathogenesis of Tourette's syndrome. , 1997, Journal of child psychology and psychiatry, and allied disciplines.

[57]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .

[58]  M. Benahmed,et al.  Low Doses of Bisphenol A Promote Human Seminoma Cell Proliferation by Activating PKA and PKG via a Membrane G-Protein–Coupled Estrogen Receptor , 2009, Environmental health perspectives.

[59]  J. Sumpter,et al.  Structural Features of Alkylphenolic Chemicals Associated with Estrogenic Activity* , 1997, The Journal of Biological Chemistry.

[60]  L. Schuler,et al.  Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor α and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[61]  M. Bagchi,et al.  Recruitment of Distinct Chromatin-modifying Complexes by Tamoxifen-complexed Estrogen Receptor at Natural Target Gene Promoters in Vivo* , 2004, Journal of Biological Chemistry.

[62]  B. Katzenellenbogen,et al.  The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC‐12 cells , 2008, Journal of neurochemistry.

[63]  O. Kwon,et al.  COMPARATIVE EVALUATION OF ALKYLPHENOLIC COMPOUNDS ON ESTROGENIC ACTIVITY IN VITRO AND IN VIVO , 2002, Journal of toxicology and environmental health. Part A.

[64]  R. Santen,et al.  Estrogen rapid action via protein complex formation involving ERalpha and Src. , 2005, Trends in endocrinology and metabolism: TEM.

[65]  B R Christopher,et al.  FIFTEEN YEARS AFTER , 1999 .

[66]  D. Gorenstein,et al.  Structure and dynamics of cytochrome c in nonaqueous solvents by 2D NH-exchange NMR spectroscopy , 1993 .

[67]  C. Portier,et al.  Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. , 1997, Toxicology and applied pharmacology.

[68]  I. Quesada,et al.  The pancreatic β-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes , 2009, Molecular and Cellular Endocrinology.

[69]  J. Sellés,et al.  Novel action of estrone on vascular tissue: regulation of NOS and COX activity , 2005, Steroids.

[70]  Cheryl S Watson,et al.  Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses , 2004, Breast Cancer Research.

[71]  H. Matsushita,et al.  Identification and quantification of chlorinated bisphenol A in wastewater from wastepaper recycling plants. , 2001, Chemosphere.

[72]  J. Oehlmann,et al.  Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response , 2005, Human & experimental toxicology.

[73]  C. Otto,et al.  In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[74]  H. Adlercreutz,et al.  Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. , 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[75]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[76]  R. Alyea,et al.  Differential Regulation of Dopamine Transporter Function and Location by Low Concentrations of Environmental Estrogens and 17β-Estradiol , 2009, Environmental health perspectives.

[77]  R McKinlay,et al.  Calculating human exposure to endocrine disrupting pesticides via agricultural and non-agricultural exposure routes. , 2008, The Science of the total environment.

[78]  C. Watson,et al.  Alkylphenol Xenoestrogens with Varying Carbon Chain Lengths Differentially and Potently Activate Signaling and Functional Responses in GH3/B6/F10 Somatomammotropes , 2008, Environmental health perspectives.

[79]  L. Schuler,et al.  Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice , 2003, Oncogene.

[80]  R. Habert,et al.  Estrogen effects on fetal and neonatal testicular development. , 2006, Reproduction.

[81]  G. Litwack Biochemical Actions of Hormones , 2012 .

[82]  J. Gorski,et al.  Estrogens and the genetic control of tumor growth. , 1997, Progress in clinical and biological research.

[83]  A. Norman,et al.  A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. , 2002, Biochemical and biophysical research communications.

[84]  C. Watson,et al.  Xenoestrogens at Picomolar to Nanomolar Concentrations Trigger Membrane Estrogen Receptor-α–Mediated Ca2+ Fluxes and Prolactin Release in GH3/B6 Pituitary Tumor Cells , 2005, Environmental health perspectives.

[85]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[86]  D. Dluzen,et al.  Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system , 2005, Pharmacology Biochemistry and Behavior.

[87]  S. Deventer,et al.  A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. , 2000, The Biochemical journal.

[88]  R. Kurlan The pathogenesis of Tourette's syndrome. A possible role for hormonal and excitatory neurotransmitter influences in brain development. , 1992, Archives of neurology.

[89]  Gerald T Ankley,et al.  Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[90]  P. Whitten,et al.  Cross-species and interassay comparisons of phytoestrogen action. , 2001, Environmental health perspectives.

[91]  T. Walle,et al.  HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.

[92]  R. Einspanier,et al.  Amphibians as a model to study endocrine disruptors: II. Estrogenic activity of environmental chemicals in vitro and in vivo. , 1999, The Science of the total environment.

[93]  F. B. Davis,et al.  Effects of Resin or Charcoal Treatment on Fetal Bovine Serum and Bovine Calf Serum , 2009, Endocrine research.

[94]  H. Adlercreutz Phytoestrogens: epidemiology and a possible role in cancer protection. , 1995, Environmental health perspectives.

[95]  J. Croué,et al.  Chlorination of bisphenol A: kinetics and by-products formation. , 2004, Chemosphere.

[96]  C. Watson,et al.  Xenoestrogen-Induced ERK-1 and ERK-2 Activation via Multiple Membrane-Initiated Signaling Pathways , 2004, Environmental health perspectives.

[97]  D. Kolpin,et al.  Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams , 2005 .

[98]  J. Corton,et al.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.

[99]  L. Gooren,et al.  Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. , 2008, European journal of endocrinology.

[100]  P. Quinn Treating adolescent girls and women with ADHD: gender-specific issues. , 2005, Journal of clinical psychology.

[101]  S. Hankinson,et al.  The role of prolactin in mammary carcinoma. , 2003, Endocrine reviews.

[102]  C. Watson,et al.  Membrane estrogen receptor-α-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells , 2009, Journal of molecular signaling.

[103]  M. Michel,et al.  Ligand-Directed Signaling: 50 Ways to Find a Lover , 2007, Molecular Pharmacology.

[104]  E. Stefani,et al.  Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα , 2008, PloS one.

[105]  J. Westendorf,et al.  Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. , 2001, Toxicology.

[106]  O. Jänne,et al.  Differential sensitivity of specific genes in mouse kidney to androgens and antiandrogens , 1985 .

[107]  R. Bigsby,et al.  The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. , 1997, Endocrinology.

[108]  S. Shenhav,et al.  Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome , 2003, Acta obstetricia et gynecologica Scandinavica.

[109]  John Peterson Myers,et al.  A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health , 2009, Environmental health perspectives.